Lima Ricardo, Ribeiro Felipe C, Colombo Arnaldo L, de Almeida Joăo N
Special Mycology Laboratory, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Clinical Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Front Fungal Biol. 2022 Aug 15;3:957021. doi: 10.3389/ffunb.2022.957021. eCollection 2022.
Antifungal resistance in humans, animals, and the environment is an emerging problem. Among the different fungal species that can develop resistance, is ubiquitous and causes infections in animals and humans. In Asia and some Latin American countries, is among the most common species related to candidemia, and mortality rates are usually above 40%. Fluconazole resistance is especially reported in Asian countries and clonal spread in humans and the environment has been investigated in some studies. In Brazil, high rates of azole resistance have been found in animals and the environment. Multidrug resistance is still rare, but recent reports of clinical multidrug-resistant isolates are worrisome. The molecular apparatus of antifungal resistance has been majorly investigated in clinical isolates, revealing that this species can develop resistance through the conjunction of different adaptative mechanisms. In this review article, we summarize the main findings regarding antifungal resistance and through an "One Health" approach.
人类、动物和环境中的抗真菌耐药性是一个新出现的问题。在能够产生耐药性的不同真菌物种中, 无处不在,并在动物和人类中引起感染。在亚洲和一些拉丁美洲国家, 是与念珠菌血症相关的最常见物种之一,死亡率通常高于40%。亚洲国家尤其报告了氟康唑耐药性,并且一些研究已经调查了其在人类和环境中的克隆传播。在巴西,在动物和环境中发现了高比例的唑类耐药性。多重耐药性仍然很少见,但最近关于临床多重耐药分离株的报告令人担忧。抗真菌耐药性的分子机制主要在临床 分离株中进行了研究,结果表明该物种可以通过不同适应机制的结合产生耐药性。在这篇综述文章中,我们通过“同一健康”方法总结了关于抗真菌耐药性和 的主要发现。